Platanic acid derived amides are more cytotoxic than their corresponding oximes

被引:4
作者
Kozubek, Marie [1 ]
Hoenke, Sophie [1 ]
Schmidt, Theresa [1 ]
Stroehl, Dieter [1 ]
Csuk, Rene [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Organ Chem, Kurt Mothes Str 2, D-06120 Halle, Saale, Germany
关键词
Platanic acid; cytotoxicity; SRB assay; PARKINSON-DISEASE; XANTHINE-OXIDASE; POTENT INHIBITORS; BETULINIC ACID; RHODAMINE-B; DERIVATIVES; HYPERURICEMIA; MECHANISMS; DEMENTIA; CANCER;
D O I
10.1007/s00044-022-02902-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Albeit platanic acid has been known since 1956, its potential to act as a valuable starting material for the synthesis of cytotoxic agents has been neglected for many years. Hereby we describe the synthesis of a small library of amides and oximes derived from 3-O-acetyl-platanic acid, and the results of their screening as cytotoxic agents for several human tumor cell lines. As a result, while the cytotoxicity of the oximes was diminished as compared to the parent amides, the homopiperazinyl amide 5 held the highest cytoxicity (EC50 = 0.9 mu M for A375 human melanoma cells). Extra FACS and cell cycle measurements showed compound 5 to act onto A375 cells rather by apoptosis than by necrosis. [GRAPHICS] .
引用
收藏
页码:1049 / 1059
页数:11
相关论文
共 46 条
[1]  
Ali MS, 2021, J CHEM SOC PAKISTAN, V43, P606
[2]   CHEMISTRY OF TRITERPENES AND RELATED COMPOUNDS .43. CONSTITUENTS OF BARK OF PLATANUS X HYBRIDA BROT AND STRUCTURE OF PLATANIC ACID [J].
APLIN, RT ;
HALSALL, TG ;
NORIN, T .
JOURNAL OF THE CHEMICAL SOCIETY, 1963, :3269-&
[3]   Parkinson disease [J].
Balestrino, R. ;
Schapira, A. H., V .
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (01) :27-42
[4]   Preparation of betulinic acid derivatives by chemical and biotransformation methods and determination of cytotoxicity against selected cancer cell lines [J].
Baratto, Leopoldo C. ;
Porsani, Mariana V. ;
Pimentel, Ida C. ;
Pereira Netto, Adaucto B. ;
Paschke, Reinhard ;
Oliveira, Bras H. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 68 :121-131
[5]   Xanthine oxidoreductase in cancer: more than adifferentiation marker [J].
Battelli, Maria Giulia ;
Polito, Letizia ;
Bortolotti, Massimo ;
Bolognesi, Andrea .
CANCER MEDICINE, 2016, 5 (03) :546-557
[6]   Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[7]   Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia [J].
Bohnen, NI ;
Kaufer, DI ;
Hendrickson, R ;
Ivanco, LS ;
Lopresti, BJ ;
Constantine, GM ;
Mathis, CA ;
Davis, JG ;
Moore, RY ;
DeKosky, ST .
JOURNAL OF NEUROLOGY, 2006, 253 (02) :242-247
[8]   Progress towards the discovery of xanthine oxidase inhibitors [J].
Borges, F ;
Fernandes, E ;
Roleira, F .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :195-217
[9]   Pharmacological Treatment of Parkinson Disease A Review [J].
Connolly, Barbara S. ;
Lang, Anthony E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16) :1670-1683
[10]   Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67